Apple and Johnson & Johnson to collaborate on Heart health study

Janssen Pharmaceuticals, Inc., member of the Johnson & Johnson Family of Companies and Apple Inc. are collaborating in a multi-year research program to find out the early detection of atrial fibrillation(AFib). The health program with an app developed by Johnson and Johnson will work with apple watch which has optical heart sensor and ECG app.

Image source: Apple

The research focus on finding the early symptoms of AFib with Apple watch series 4. Atrial Fibrillation is defined as irregularity and abnormality of heartbeat in the upper part of the heart. It can cause heart stroke, heart failure or death. At least 2.7 American suffer from AFib. Out of which, only 33% of them considered it to be serious illness until potentially threatened condition arises.

I had no symptoms at all. I discovered my AF at a regular check-up. I am glad we found it early”, said some patient.

Instead of tracking individual patient, the goal of the study is to aggregate data from group studies. It is only applicable to 65 years old or above US adults who wear apple watch series 4. This study will tell us about how wearable technology can help us in health conditions. Details about participating in this program will be released later.
Paul Stoffels, Johnson & Johnson’s executive vice president and chief scientific officer, said: “the goal is to identify early on AFib and prevent stroke by combining the physical know-how from Apple and what we have from the medical and scientific know-how.”

Apple watch series four features optical heart sensor which triggers a notification whenever a heartbeat is abnormal. The ECG app can record user’s heartbeat, and rhythm using the electrical heart sensor on Apple watch series checking the recording for AFib. The user’s doctor can use the recorded ECG reading.

“We are receiving thank you letters daily from Apple Watch wearers who are discovering they have AFib,” said Apple Chief Operating Officer Jeff Williams. “We want a deeper understanding about outcomes and prevention associated with early detection. We are excited to work with Johnson & Johnson, which has a long history and expertise in cardiovascular disease.”

Previously, Apple Inc. has collaborated with Stanford University in “Apple Heart Study.” American Heart Journal said it to be the largest screening study on atrial fibrillation ever done. Final research in collaboration with the pharmaceutical company will release later this year.

“This collaboration brings together Johnson & Johnson’s depth of expertise and long heritage in treating cardiovascular disease with Apple’s experience in utilizing cutting-edge technologies to improve the lives of consumers,” Paul Burton said on working together of both the companies.

About the author

Vibhuti Kushwaha

Vibhuti Kushwaha has been writing for a long time. She enjoys writing about health and tech stuff. Her educational background of computer science helps her to write deeply about technology. She writes engaging and valuable health related articles.

Add Comment

Click here to post a comment